Okay, let's tackle this question. The user is asking about gastrointestinal hormones that stimulate insulin secretion. First, I need to recall which GI hormones are involved in insulin regulation. I remember that incretin hormones are key here. The main ones are GLP-1 and GIP. GLP-1, or glucagon-like peptide-1, is released from the L-cells in the intestine after meals. It enhances insulin secretion in a glucose-dependent manner, which is why it's used in type 2 diabetes medications. GIP, glucose-dependent insulinotropic polypeptide, is from K-cells in the duodenum and also stimulates insulin release.

Now, looking at the options, the correct answer should include both GLP-1 and GIP. Let me check the options again. The user didn't list the options, but based on common MCQs, the options might be things like gastrin, CCK, secretin, etc. For example, if the options were A. Gastrin, B. CCK, C. GIP, D. GLP-1, then the correct answer would be C and D. But since the user didn't provide the options, I need to make sure that in my explanation, I cover the correct hormones and why others are wrong.

Other GI hormones like gastrin, CCK, and secretin don't stimulate insulin. Gastrin is involved in gastric acid secretion. CCK is for gallbladder contraction and pancreatic enzyme release. Secretin stimulates bicarbonate secretion from the pancreas. So those are not involved in insulin secretion. The key here is that the incretin effect is mediated by GLP-1 and GIP. The clinical pearl would be that GLP-1 agonists are used in diabetes management because they enhance insulin secretion postprandially. Also, the mnemonic could be "GIP and GLP-1" for the two main incretins. I need to structure the explanation with core concept, correct answer explanation, why others are wrong, and a clinical pearl. Make sure each section is concise and uses proper medical terms. Let me put this all together now.

**Core Concept**
Gastrointestinal (GI) hormones, particularly incretin hormones like **glucagon-like peptide-1 (GLP-1)** and **glucose-dependent insulinotropic polypeptide (GIP)**, stimulate insulin secretion from pancreatic beta cells in response to nutrient intake. These hormones amplify insulin release in a glucose-dependent manner, enhancing postprandial glycemic control.

**Why the Correct Answer is Right**
**GLP-1** is secreted by intestinal L-cells and activates GLP-1 receptors on beta cells, increasing intracellular cAMP. This promotes calcium influx, ATP-dependent potassium channel closure, and exocytosis of insulin granules. **GIP**, released by K-cells in the duodenum, binds to GIP receptors on beta cells, triggering similar signaling pathways. Both hormones are critical for the "incretin effect," where oral glucose induces greater insulin secretion than intravenous glucose.

**Why Each Wrong Option is Incorrect**
**Option A (e.g., Gastrin):** Stimulates gastric acid secretion and gastric motility; no direct role in insulin secretion.
**Option B (e.g., Cholecystokinin/CCK):** Mediates gallbladder

✓ Correct Answer: D. All of the above